The CDC assisted with the public health response to the devastating tsunami in the Indian Ocean
On Dec. 26, 2004, the U.S. Centers for Disease Control and Prevention (CDC) assisted with an earthquake measuring…
On Dec. 26, 2004, the U.S. Centers for Disease Control and Prevention (CDC) assisted with an earthquake measuring…
On Dec. 20, 2004, the Clinical Outcomes Research Initiative (CORI) based at OHSU anounnced it had received a…
On Dec. 15, 2004, Amgen announced that following priority review, the FDA has approved Kepivance(TM) (palifermin), the first…
On Dec. 10, 2004, a National Cancer Institute supported study determined that a new molecular test byin collaboration…
In Dec. 2004, David H. Murdock purchased the former Cannon Mills site at auction, future home of the…
In Dec. 2004, TGen and IGC moved into their new state-of-the-art headquarters. The six-story, $46 million building forms…
On Nov. 18, 2004, Genentech drug Tarceva (erlotinib) was approved by the FDA for patients with advanced non-small…
On Nov. 18, 2004, scientists at the National Cancer Institute created a model that predicts the survival of…
On Nov. 2, 2004, the California Institute for Regenerative Medicine was established with the passage of Proposition 71,…
On Nov. 1, 2004, a OHSU research team announced that it was one of only 14 teams around…
On Oct. 6, 2004, the NIH awarded scientists from Emory University and the Georgia Institute of Technology two…
On Oct. 4, 2004, the Nobel Assembly announced the award of the Nobel Prize in Physiology or Medicine…
In Oct. of 2004, the Hotchkiss Brain Institute was launched under the leadership of Dr. Samuel Weiss with…
On Sept. 30, 2003, UI Microbiology Professor Mark Stinski made the discoveries of CMV promoter and was named…
On Sept. 29, 2004, a team from scientists from the Pacific Northwest National Laboratory and Oregon Health &…
On Sept. 22, 2004, the National Institutes of Health opened the Mark O. Hatfield Clinical Research Center, a…
On Sept. 14, 2004, researchers at OHSU and OHSU’s Vaccine and Gene Therapy Institute announced a collaboration with…
On Sept. 13, 2004, the National Cancer Institute announced the Alliance for Nanotechnology in Cancer, a 5-year initiative…
On Aug. 25, 2004, a significant shortage of influenza vaccine occurred in the U.S. as a result of…
On Aug. 4, 2004, the Barbara Ann Karmanos Cancer Institute announced plans to build a $47 million clinical…
On Aug. 24, 2004, Eli Lilly and Company launched Cymbaltaï¾® (duloxetine HC), a new treatment for major depression…
On Aug. 2, 2004, to provide for the treatment of animal species other than cattle, horses, swine, chickens,…
On Jul. 21, 2004, Project BioShield Act of 2004 was signed by President Bush. The Act authorized the…
On Jul. 16, 2004, a National Cancer Institute Phase I clinical trial was underway to test the safety…
On Jun. 26, 2004, the 8th and final report of the Immunization Safety Review Committee was issued by…
On Jun. 16, 2004, Portland’s Schnitzer Investment Corp. donated OHSU with a gift of nearly 20 acres of…
On Jun. 3, 2004, the National Cancer Institute’s Annual Report to the Nation found cancer incidence and death…
On May 27, 2004, two-year contracts were awarded to Aventis Pasteur and to Chiron to develop vaccine against…
On May 25, 2004, researchers at the Vaccine and Gene Therapy Institute (VGTI) and the Oregon National Primate…
On May 20, 2004, the Medicare Prescription Drug Improvement and Modernization Act required, among other elements, that a…